Viewing Study NCT02153905

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:31 AM
Ignite Modification Date: 2026-06-16 @ 7:42 PM
Study NCT ID: NCT02153905
Status: TERMINATED
Last Update Posted: 2019-06-17
First Post: 2014-05-31
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-A*01 Positive
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
None Cervical Cancer View
None Renal Cancer View
None Melanoma View
None Bladder Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Melanoma View
None Immunotherapy View
None Metastatic Cancer View
None Gene Therapy View
None T Cells View